Following their gains last week, Pfizer Inc (PFE) (-3.34 percent) and BioNTech SE (BNTX) (-13.66 percent) are the target of sustained profit-taking, while Moderna Inc (MRNA) (+9.58%) profits from its announcement.

After Moderna’s announcements, European markets ended well in the green (up 0.99 percent for the EuroStoxx 50) earlier in the day and Asia also performed well (up 2 percent for the Nikkei). Broader economic hopes were also boosted by optimistic market sentiment, while the latest Chinese industrial output figures (up 6.9 percent) surpassed expectations. Japan’s GDP also rebounded more than expected in the third quarter (up 5% from a consensus of 4.4%).

Several U.S. economic indicators suggest that household optimism and credit card spending slowed in November, although almost half of the 22 million jobs lost last spring, amid the powerful economic recovery that began across the Atlantic this summer, have not yet been recreated. On the other hand, it should be noticed that the consensus (up 4.3 percent versus 5.1 percent) was missed by Chinese retail sales. China’s unemployment rate came out at 5.3%, in line with expectations. The industrial output of Japan, up 3.9 percent, reported a result comparable to consensus.

The Chinese e-commerce company listed on Wall Street, Inc (JD) (-7.41 percent), posted sales increased by 29 percent in the third quarter, with online orders for critical goods remaining high despite the lifting of coronavirus restrictions in China.

As the meat processor benefited from demand for containment steps, Tyson Foods INC (TSN) (up 3.83 per cent) posted stronger-than-expected quarterly revenue growth. There was $692 million in quarterly net income, or $1.90 per share, compared to $369 million a year earlier. The adjusted EPS went up 50 percent to $1.81.

Caesars Entertainment, Inc. (CZR) rose 2.95 percent. Fred Done, the largest shareholder of William Hill, will endorse the bid to acquire Caesars for EUR 2.9 billion, reported the Telegraph.